The FDA’s outside vaccine advisers overwhelmingly recommended Thursday that the agency direct manufacturers to base their 2026-2027 formulas on the dominant XFG Covid variant.

GAITHERSBURG, Md., Aug. 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced the Novavax COVID-19 ...

Thursday, the FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP ...

Vaccines work pretty well. But with a little help, they could work better. Stanford researchers have developed a new vaccine helper that combines two kinds of adjuvants, ingredients that improve a ...

A committee of advisers to the Food and Drug Administration voted Wednesday to update the formula for the COVID-19 vaccine before an anticipated fall immunization campaign, now an annual step to try ...